Assertion: codalgin forte | /r/HasProperty | contraindicated
Facets:
value: for use in patients
type: PURPOSE
value: for use in children
type: PURPOSE
value: for use during breastfeeding
type: PURPOSE
Source sentences:
text: Codalgin Forte is contraindicated for use in patients who are CYP2D6 ultrarapid metabolisers (see Precautions, CYP2D6 metabolism); younger than 12 years (see Precautions, Use in children); aged between 12-18 years in whom respiratory function might be compromised, including post-tonsillectomy and/or adenoidectomy for obstructive sleep apnoea, due to an increased risk of developing serious and life threatening adverse reactions (see Precautions, Use in children); breastfeeding (see Precautions, Use in lactation).
text: Codalgin Forte is contraindicated for use in patients who are CYP2D6 ultrarapid metabolisers.
text: Codalgin Forte is contraindicated during breastfeeding (see CYP2D6 metabolism) due to risk of respiratory depression in the infant.
text: Therefore, Codalgin Forte is contraindicated for use during breastfeeding.
text: Codalgin Forte is contraindicated for use in children younger than 12 years; aged between 12-18 years in whom respiratory function might be compromised, including post-tonsillectomy and/or adenoidectomy for obstructive sleep apnoea.
text: Codalgin Forte is contraindicated for use in patients who are younger than 12 years; aged between 12-18 years in whom respiratory function might be compromised, including post-tonsillectomy and/or adenoidectomy for obstructive sleep apnoea.
text: Codalgin Forte is contraindicated for use in patients who are younger than 12 years; aged between 12-18 years in whom respiratory function might be compromised, including post-tonsillectomy and/or adenoidectomy for obstructive sleep apnoea.